Neoadjuvant Therapy–Associated CDX2 Expression and Its Prognostic Implication in Esophageal Adenocarcinoma

Heong Ahn, Madhurya Ramineni, Hangchuan Shi, Rena X. Li, Moises Velez, Yansheng Hao

Open source

DOI
10.1016/j.labinv.2025.104135
Published
2025-06
Container
Laboratory Investigation
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.labinv.2025.104135,
  title = {Neoadjuvant Therapy–Associated CDX2 Expression and Its Prognostic Implication in Esophageal Adenocarcinoma},
  author = {Heong Ahn and Madhurya Ramineni and Hangchuan Shi and Rena X. Li and Moises Velez and Yansheng Hao},
  year = {2025},
  journal = {Laboratory Investigation},
  doi = {10.1016/j.labinv.2025.104135},
  url = {https://doi.org/10.1016/j.labinv.2025.104135}
}

RIS

TY  - JOUR
TI  - Neoadjuvant Therapy–Associated CDX2 Expression and Its Prognostic Implication in Esophageal Adenocarcinoma
AU  - Heong Ahn
AU  - Madhurya Ramineni
AU  - Hangchuan Shi
AU  - Rena X. Li
AU  - Moises Velez
AU  - Yansheng Hao
PY  - 2025
JO  - Laboratory Investigation
DO  - 10.1016/j.labinv.2025.104135
UR  - https://doi.org/10.1016/j.labinv.2025.104135
ER  - 

APA

Ahn, H., Ramineni, M., Shi, H., Li, R. X., Velez, M., & Hao, Y. (2025). Neoadjuvant Therapy–Associated CDX2 Expression and Its Prognostic Implication in Esophageal Adenocarcinoma. Laboratory Investigation. https://doi.org/10.1016/j.labinv.2025.104135

Source records